Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endogen was a prominent biotechnology company specializing in the development and manufacture of research tools for the study of immunology and inflammation. The company was widely recognized for its extensive catalog of high-quality ELISA kits, recombinant cytokines, and monoclonal antibodies used in life science research. Founded in 1983 and based in Woburn, Massachusetts, Endogen became a key supplier for academic and pharmaceutical laboratories worldwide. Following a series of acquisitions, the Endogen brand and its product portfolio were eventually integrated into Thermo Fisher Scientific, where they continue to support cytokine and chemokine research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Endogen.